Related Pages for UPL
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
UPL
Related News - UPL
UPL: HSBC on UPL Maintains Buy with Target Price of ₹880 as resilient Q1FY27 performance across businesses, FY27 EBITDA growth guidance of 10–14%, restructuring progress on track, and attractive FY28 valuation support outlook.
04 Aug 2026 08:59 AM
UPL: HSBC on UPL Maintains Buy with Target Price of ₹880 as resilient Q1FY27 performance across businesses, FY27 EBITDA growth guidance of 10–14%, restructuring progress on track, and attractive FY28 valuation support outlook.
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, restructuring milestones, Advanta IPO progress, crop protection reorganization, and margin focus offset cautious demand outlook.
04 Aug 2026 08:59 AM
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, restructuring milestones, Advanta IPO progress, crop protection reorganization, and margin focus offset cautious demand outlook.
UPL: Jefferies on UPL Maintains Buy with Target Price of ₹715 as despite EBITDA and PAT missing estimates, FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, 21% stock correction, and expected 14% FY27 EBITDA growth support the outlook.
04 Aug 2026 08:59 AM
UPL: Jefferies on UPL Maintains Buy with Target Price of ₹715 as despite EBITDA and PAT missing estimates, FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, 21% stock correction, and expected 14% FY27 EBITDA growth support the outlook.
UPL: Guidance - UPL delivered on its Q1 guidance and expects full-year FY27 revenue growth of 7% to 11% and EBITDA growth of 10% to 14%.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - UPL delivered on its Q1 guidance and expects full-year FY27 revenue growth of 7% to 11% and EBITDA growth of 10% to 14%.- Concall Update
UPL: Guidance - Management is confident in delivering a strong Q2 and meeting full-year commitments, with growth expected to be volume-led for the remainder of the year.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - Management is confident in delivering a strong Q2 and meeting full-year commitments, with growth expected to be volume-led for the remainder of the year.- Concall Update
UPL: Guidance - The seeds and super specialty businesses are expected to continue strong growth, with India's business performance dependent on monsoon conditions.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - The seeds and super specialty businesses are expected to continue strong growth, with India's business performance dependent on monsoon conditions.- Concall Update
UPL: Guidance - For global crop protection, volume recovery is anticipated as growers will use necessary products, and UPL aims for market share growth.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - For global crop protection, volume recovery is anticipated as growers will use necessary products, and UPL aims for market share growth.- Concall Update
UPL: Guidance - The company expects to achieve $115 million in revenue from new product launches this year and anticipates improved EBITDA margins for the full year.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - The company expects to achieve $115 million in revenue from new product launches this year and anticipates improved EBITDA margins for the full year.- Concall Update
UPL: FY27 EBITDA GROWTH GUIDANCE OF 10-14%
03 Aug 2026 03:26 PM
UPL: FY27 EBITDA GROWTH GUIDANCE OF 10-14%
UPL: FY27 REVENUE GROWTH GUIDANCE OF 7-11%
03 Aug 2026 03:27 PM
UPL: FY27 REVENUE GROWTH GUIDANCE OF 7-11%
UPL: Q1 CONS NET PROFIT 100M RUPEES VS LOSS 880M (YOY)
03 Aug 2026 03:18 PM
UPL: Q1 CONS NET PROFIT 100M RUPEES VS LOSS 880M (YOY)
UPL: Q1 EBITDA 14.5B RUPEES VS 13.96B (YOY) || Q1 EBITDA MARGIN 14.24% VS 15.15% (YOY)
03 Aug 2026 03:19 PM
UPL: Q1 EBITDA 14.5B RUPEES VS 13.96B (YOY) || Q1 EBITDA MARGIN 14.24% VS 15.15% (YOY)
UPL: Q1 REVENUE 102B RUPEES VS 92B (YOY)
03 Aug 2026 03:19 PM
UPL: Q1 REVENUE 102B RUPEES VS 92B (YOY)
UPL: Subsidiary UPL Brasil Gets Green Light to Sell Full Stake in Bioplanta JV
29 Jul 2026 08:39 PM
UPL: Subsidiary UPL Brasil Gets Green Light to Sell Full Stake in Bioplanta JV
Govt Bans Permanent Sale Of Paraquat Dichloride || Upl Has Good Portfilio In Paraquat - Govt Order
15 Jul 2026 01:08 PM
Govt Bans Permanent Sale Of Paraquat Dichloride || Upl Has Good Portfilio In Paraquat - Govt Order
UPL: Company Confirms It Will Meet Q1 Goals And Anticipates Strong Results In Upcoming Quarters
02 Jul 2026 09:55 AM
UPL: Company Confirms It Will Meet Q1 Goals And Anticipates Strong Results In Upcoming Quarters
UPL: HSBC on UPL Buy, Target Price ₹880, citing optimistic Punjab channel checks, better farmer cash flows driving 5–10% ag-input demand growth in 1QFY27 despite delayed sowing, and attractive valuation at 5.4x FY28E EV/EBITDA.
30 Jun 2026 08:48 AM
UPL: HSBC on UPL Buy, Target Price ₹880, citing optimistic Punjab channel checks, better farmer cash flows driving 5–10% ag-input demand growth in 1QFY27 despite delayed sowing, and attractive valuation at 5.4x FY28E EV/EBITDA.
UPL: InCred downgrades UPL Limited to Hold with a Target Price of ₹659, citing pressure on its post-patent agrochemical portfolio from Chinese overcapacity and exports impacting key molecules, valuing the stock at 1.3x FY28F P/BV, with risks from further dumping offset by potential upside from supply-chain disruptions lifting chemical prices.
16 Jun 2026 08:47 AM
UPL: InCred downgrades UPL Limited to Hold with a Target Price of ₹659, citing pressure on its post-patent agrochemical portfolio from Chinese overcapacity and exports impacting key molecules, valuing the stock at 1.3x FY28F P/BV, with risks from further dumping offset by potential upside from supply-chain disruptions lifting chemical prices.
CCI approves proposed combination related to restructuring of UPL group companies and others - PIB
03 Jun 2026 01:05 PM
CCI approves proposed combination related to restructuring of UPL group companies and others - PIB
UPL: HSBC maintains a Buy on UPL with a Target Price of ₹880 (cut), citing a strong 4QFY26 beat led by Global Crop Protection and Advanta businesses with growth across all regions except India, while noting that UPL exceeded all FY26 guidance parameters and its strengthened balance sheet leaves it well-positioned to navigate ongoing uncertainties.
13 May 2026 08:39 AM
UPL: HSBC maintains a Buy on UPL with a Target Price of ₹880 (cut), citing a strong 4QFY26 beat led by Global Crop Protection and Advanta businesses with growth across all regions except India, while noting that UPL exceeded all FY26 guidance parameters and its strengthened balance sheet leaves it well-positioned to navigate ongoing uncertainties.
